Advanced Search…
  • Models Home
  • Exposures
  • Documentation
  • Log in
You are here: Home / Exposures / Bonhoeffer, Rembiszewski, Ortiz, Nixon, 2000 / Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection
Info

Generated Code

The following is python code generated by the CellML API from this CellML file. (Back to language selection)

The raw code is available.

Model is underconstrained.
The following variables couldn't be defined:
 * T in component T
 * d/dt T in component T
 * d/dt I in component I
 * d/dt Il in component Il
 * d/dt E in component E
Source
Derived from workspace Bonhoeffer, Rembiszewski, Ortiz, Nixon, 2000 at changeset a48e6d79860d.
This exposure was expired. A more up-to-date exposure is available, or view related resources.
Collaboration
To begin collaborating on this work, please use your git client and issue this command:
Downloads
  • Download This File
  • Complete Archive as .tgz
  • COMBINE Archive (exposure)
Views Available
  • Documentation
  • Model Metadata
  • Mathematics
  • Generated Code
  • Cite this model
  • Source View
  • Semantic Metadata
  • Launch with OpenCOR
Tools
  • CombineArchive Web
  • Compare...
  • Export Exposure Metadata
  • Report a problem with this resource
License

This work is licensed under a Creative Commons Attribution 3.0 Unported License.

Navigation
  • Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection
  • Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection
  • Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection
  • Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection
© 2001-2026 - IUPS Physiome Project.
  • Site Map
  • Accessibility
  • Contact
  • About